Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer.

R F Ozols1, S D Williams

  • 1Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Current Problems in Cancer
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Testicular cancer, though rare, is the most common cancer in young men. Advances in diagnosis and treatment have made it highly curable, with survival rates exceeding 90%.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutral Silicon-Vacancy Center in Diamond: Spin Polarization and Lifetimes.

Physical review letters·2017
Same author

Medication safety at the interface: evaluating risks associated with discharge prescriptions from mental health hospitals.

Journal of clinical pharmacy and therapeutics·2015
Same author

If you only have a few minutes with a drug addict.

BMJ (Clinical research ed.)·2015
Same author

Epigenetics: a new frontier in dentistry.

Australian dental journal·2014
Same author

Aural plaques in two imported horses in New Zealand.

New Zealand veterinary journal·2013
Same author

Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis.

Clinical and experimental immunology·2013
Same journal

When should the medical oncologist call the surgeon?

Current problems in cancer·2026
Same journal

Clinical impact of a single time-point protocol paired FDG-PET and radioactive iodine scan for comprehensive disease assessment in differentiated thyroid cancer.

Current problems in cancer·2026
Same journal

Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database.

Current problems in cancer·2026
Same journal

Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer.

Current problems in cancer·2026
Same journal

Artificial intelligence, omics, and biomarkers: Redefining lung cancer early detection.

Current problems in cancer·2026
Same journal

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.

Current problems in cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Urologic Oncology

Background:

  • Testicular cancer is the most common malignancy in men aged 15-35 in the U.S.
  • Historically, it was a leading cause of cancer death in this demographic.
  • Recent diagnostic and therapeutic advancements mark significant progress in solid tumor treatment.

Purpose of the Study:

  • To review the major achievements in testicular cancer diagnosis and treatment.
  • To highlight the current high curability of testicular cancer.
  • To outline future goals for reducing mortality and treatment-related morbidity.

Main Methods:

  • Review of diagnostic modalities for testicular cancer.
  • Analysis of treatment strategies and outcomes.
  • Evaluation of survival rates and morbidity associated with treatment.

Related Experiment Videos

Main Results:

  • Testicular cancer is now one of the most curable cancers.
  • The 5-year relative survival rate for testicular cancer exceeds 90%.
  • Projected deaths from testicular cancer in the U.S. in 1989 are fewer than 500.

Conclusions:

  • Dramatic improvements in survival have been achieved through advances in diagnosis and treatment.
  • Future efforts will focus on further reducing mortality and minimizing treatment-related side effects.